Objective. We elaborated the rat hippocampi in order to assess for central nervous system changes following a peripheral neuropathic injury. Conclusions. Our results showed that the peripheral nerve injury altered rat hippocampal miRNA.
Introduction
The mechanism of neuropathic pain remains unknown, and it is difficult to treat in many cases. Rats with chronic constriction injury (CCI) show thermal and mechanical hypersensitivity. Previous reports have revealed that some messenger RNAs (mRNAs) related to inflammatory cytokines [1] , cell adhesion factors [2] , and neurotransmitters cause changes in the brain, nerves, and dorsal root ganglion to generate neuropathic pain [3, 4] . The regeneration of neurons, differentiation of stem cells, immigration of immune cells, and the repair of damaged axons are considered to be among the causes of neuropathic pain [3] . Reports have also indicated that changes in mRNA expression in the hypothalamus, frontal cortex, and hippocampi play important roles in neuropathic pain [5, 6] and that neuropathic pain is related to the limbic system. The hippocampus is not directly involved in pain, but researchers have reported that rats with neuropathic pain show behavioral changes related to the hippocampus [7] [8] [9] .
protein changes in the body. Moreover, miRNAs may control nerve differentiation, synaptic connections [10] , neuromuscular junctions, and dendrites [11] . Recently, some miRNA changes of the hippocampus after traumatic brain injury were reported [12, 13] .
There are only a few reports of miRNA changes in neuropathic pain models [14, 15] . We hypothesized that changes in miRNA expression in the hippocampus may influence behavioral changes in neuropathic pain by changing the mRNA expression of receptors or neurotransmitters. By clarifying miRNA changes in a neuropathic pain model, miRNA changes may become potential targets of pain control therapy. In this study, we examined hippocampal samples during the first 2 weeks of CCI using Taqman ® low-density array (TLDA) and quantitative real-time polymerase chain reaction (qRT-PCR) of miRNAs and mRNAs, which are known to be related to hippocampi and neuron activities. We found remarkable changes in miRNA expression evoked in the hippocampi of CCI rats on day 7 after the CCI operation, which tended to return to the original levels on day 15.
Methods
The experimental procedures were approved by the Institutional Committee on Laboratory Animals of Nippon Medical School (approval number: 22-161) and were performed under the guidelines of the International Association for the Study of Pain [16] . Male Sprague-Dawley rats (6-7 weeks of age, 200-250 g; Saitama Experimental Animals, Saitama, Japan) were used in all experiments. Rats were housed in clear plastic cages with sawdust bedding at standard room temperature under a 12-hour light/dark cycle. All rats received food and water ad libitum. We divided the rats into three groups: 1) a group of CCI rats that were sacrificed 15 days after the procedure (day 15 group, N = 6); 2) a group of CCI rats that were sacrificed 7 days after the procedure (day 7 group, N = 6); and 3) a group of rats that underwent no procedure (control group, N = 6).
Experimental traumatic neuropathy was produced according to a method described in detail elsewhere [17] . All surgical procedures were performed on rats under deep anesthesia with sodium pentobarbital (50 mg/kg intraperitoneally). The left (ipsilateral) common sciatic nerve was exposed in the left mid-thigh and loosely ligated using 4-0 silk thread in four regions at approximately 1-mm intervals to cause CCI. The right (contralateral) sciatic nerve was similarly exposed but not ligated as a control.
Behavioral Tests
Two behavioral tests (thermal and mechanical stimulation tests) were performed eight times to assess pain thresholds as previously described [18] : the day before surgery (day 0) and on days 1, 3, 5, 7, 9, 11, 13, and 15 after the surgery. We used the plantar test (Ugo Basile, Comerio, Italy) to examine thermal hyperalgesia. Mechanical allodynia was measured using a set of von Frey filaments (Muromachi Kikai, Saitama, Japan) with bending forces ranging from 2.0 to 32.0 g. In plantar test, each rat was placed on a glass plate with radiant heat equipment (a 50 W halogen reflector bulb) underneath. After the acclimation period, radiation heat was applied to either the contralateral or ipsilateral hindpaw pad independently. The latency of paw withdrawal from thermal stimuli was measured three times at 5-minute intervals, and the average value was used as the latency of the response. For von Frey filament testing, each rat was placed on a metallic mesh floor, covered with a plastic box, and a von Frey filament was applied from under the mesh floor to the plantar surface of either the contralateral or ipsilateral hindpaw. Each paw was stimulated with each filament five times at 10-second intervals in individual trials. The weakest force (g) inducing withdrawal of the stimulated paw at least three times in each trial was referred to as the paw withdrawal threshold.
RNA Extraction and TLDA
On day 0 before surgery or day 7 and 15 after surgery, rats were anesthetized with pentobarbital, 300 mg per 100 g intraperitoneally, and were decapitated immediately. The brains were rapidly removed, and the hippocampi were dissected as previously described [19] . Each sample was placed in Later solution ® (Applied Biosystems, LLC, Foster City, CA, USA) and stored at -80°C until used. Before used, the samples were defrosted, and Later solution was rapidly separated from the samples. Total RNA was extracted from each brain part using a mirVana MT miRNA isolation kit ® (Applied Biosystems) according to the manufacturer's instructions. RNA quantity and quality were assessed by absorbance using a NanoDrop ND-1000 (Thermo Fisher Scientific, Waltham, MA, USA). Samples with an A260/280 ratio from 1.8 up to 2.0 were of sufficient quality to use for the further analysis.
We examined changes in miRNA expression in rat hippocampal samples. Prior to TLDA, we assessed the quality of the samples by performing a qRT-PCR analysis of the endogenous control U6 small nuclear RNA (snRNA). qRT-PCR was performed as previously described [15] . TLDA supplied by Applied Biosystems is a set of miRNA low-density array analysis, which enables us to perform simultaneously qRT-PCR of 384 miRNAs including six endogenous control candidates. TLDA was performed using a Taqman Rodent miRNA Array Set v3.0 (Applied Biosystems) according to the manufacturer's instructions. The set enables accurate quantitation of mature miRNAs, all cataloged in the miRBase database (http://www. mirbase.org/), and rat endogenous control, U6 snRNA, in a two-step process. During the first step, total RNA was reverse-transcribed with predefined reverse transcription primers that are specific only to the mature miRNA species. In the second step, each of the resulting eight reverse transcription pools containing a complementary DNA template was diluted, mixed with TaqMan Gene Expression Master Mix and loaded into each of the eight fill ports on the TaqMan array. The card was briefly centrifuged twice for 1 minute at 331 ¥ g to distribute samples to the multiple wells on the array and was then sealed to prevent well-to-well contamination. Finally, cards were processed and analyzed with Applied Biosystems 7900HT fast real-time PCR system relative quantitation software (Applied Biosystems). Relative Quantification (RQ) values (relative levels of miRNA expression) were calculated by the comparative 2 -DDC T method with U6 snRNA as an endogenous control using RQ Manager 1.2.1 (Applied Biosystems) [20] . Data from low-density array analyses were analyzed using DataAssist software v2.0 (Applied Biosystems) with a threshold of 2.0 and maxCT of 35.
PCR Validation
To verify the accuracy of our TLDA data, we performed single qRT-PCR for representative miRNAs (miR-132 and miR-125b) with triplet-well TaqMan miRNA assays (Applied Biosystems) in accordance with the manufacturer's instructions. The total RNA samples used for qRT-PCR were the same samples used in the TLDA studies. The U6 snRNA miRNA was used as an endogenous control to calculate relative expression. miRNA expression levels were quantified with the 7900HT fast real-time PCR system. Relative expression was calculated by the comparative 2 -DDC T method, and data were analyzed with RQ study software (Applied Biosystems).
qRT-PCR
qRT-PCR was used to measure the levels of gene expression for neuropeptide Y (NPY), brain-derived neural factor (BDNF), N-methyl-D-aspartate glutamate 2A receptor (NR2A), gamma-aminobutyric acid A a1 receptor (GABAAa1R), gamma-aminobutyric acid A b1 receptor (GABAAb1R), gamma-aminobutyric acid B b2 receptor, serotonin 1A receptor (5HT1AR), serotonin 2A receptor (5HT2AR), serotonin 2C receptor (5HT2CR), and serotonin 3A receptor (5HT3AR) in rat hippocampi in both groups. The reverse transcription reaction was carried out using PCR Express (Thermo Fisher Scientific, Yokohama, Japan) at 42°C for 60 minutes, 99°C for 10 minutes, and 4°C for 5 minutes. A spectrophotometer was used to determine the quantity of mRNA. We examined mRNA expression changes of NPY, BDNF, NR2A, GABAAa1R, GABAAb1R, GABABb1R, 5HT1AR, 5HT2AR, 5HT2CR, and 5HT3AR of the total RNA samples with qRT-PCR using a Taqman RT kit ® and a Taqman PCR kit ® according to the manufacturer's protocol (Applied Biosystems). Amplification of mRNAs was performed in a fast 96-well reaction plate (Applied Biosystems). qRT-PCR consisted of initial denaturation at 95°C for 3 seconds, incubation at 60°C for 30 seconds, and finally, measurement of the fluorescence signal after each cycle. We chose the expression of glyceraldehyde-3-phosphate dehydrogenase as the endogenous control. The assay was performed using an instrument capable of measuring fluorescence in real time (ABI PRISM 7500 Fast Sequence Detector; Applied Biosystems).
Statistical Analysis
All numerical data were expressed as means Ϯ standard deviation. Statistical significance was determined by Tukey-Kramer's method using the c plot program (KyensLab, Inc., Tama, Japan), with the exception of behavioral test results. A paired t-test was used to compare latencies or threshold values in behavioral tests between the ipsilateral side and the contralateral side (CCI group; N = 6). Dunnett's test for multiple comparisons was used to compare latencies and threshold values obtained in behavioral tests performed before operations (day 0, N = 6) with those obtained in tests performed after operations (days 1, 3, 5, 7, 9, 11, 13, and 15; N = 6). We evaluated the expression levels of 10 mRNAs (dDt) in the hippocampi among the day 15 group (N = 6), day 7 group (N = 6), and control group (N = 6). Finally, we compared the dDt and fold change (RQ) among the three groups (N = 6). To validate TLDA data, the results from TLDA and single qRT-PCR of miRNAs were examined using the paired t-test. A minimum P value of 0.05 was estimated as the significance level for all tests.
Results

Behavioral Tests
Compared with the values on day 0, the latencies of paw withdrawal from thermal stimulation (CCI group, N = 6; Figure 1A ) and paw withdrawal thresholds in response to mechanical stimulation on the ipsilateral side (CCI group, N = 6; Figure 1B ) were decreased on days 1, 3, 5, 7, 9, 11, 13, and 15 (P < 0.01).
Results of TLDA
The results of the low-density array analysis of the hippocampi are shown in Table 1 (P < 0.05; N = 6). Out of 373 rat specific miRNAs, we detected the expression of 237 genes and divided them according to time-dependent changes into eight groups: "decrease, increase," 14 genes; "decrease, steady," 18 genes; "decrease, decrease," 0 genes; "steady, increase," 17 genes; "steady, decrease," 0 gene; "increase, increase," 0 gene; "increase, steady," 2 genes; "increase, decrease," 0 genes; and "no change," 186 genes. The cluster analyses from TLDA are shown in Figure 2 . The data of the day 7 group were separated clearly from the data of the other two groups. The data of the day 15 group had a similar trend to the data of the control group.
PCR Validation
To validate the TLDA results, we performed single qRT-PCR for miR-132 and miR-125b. miR-125b was selected from the genes that showed the most remarkable expression changes in TLDA. The RQ value of miR-125b decreased to 0.70 Ϯ 0.30 at day 7 and recovered to 1.65 Ϯ 0.19 at day 15. miR-132 was selected from genes that changed mildly. The RQ value of miR-132 decreased mildly to 0.69 Ϯ 0.15 at day 7 and 0.70 Ϯ 0.15 at day 15. The single qRT-PCR results of miR-132 and miR-125b correlated well with the results from TLDA (Table 2, Figure 3 ). The RQ value of miR-132 decreased to 0.55 Ϯ 0.23 at day 7 and remained decreased at 0.54 Ϯ 0.09 at day 15. For miR-125b, the RQ value decreased to 0.71 Ϯ 0.06 at day 7 and recovered to 1.50 Ϯ 0.07 at day 15. No statistically significant changes were observed between the results of TLDA and single qRT-PCR.
qRT-PCR of mRNAs
The results of the mRNA expression are shown in Table 2 and Figure 4 .
The expression of NPY showed a decrease on day 7 compared with the control group (P < 0.01; N = 6), and the expression of NPY on day 15 was similar to that on day 7. Changes in the GABAAa1R expression showed the same trend (P < 0.05; N = 6). The expression of BDNF and 5HT2CR mRNA decreased on day 7 and increased on ¶ P < 0.001; Dunnett's test: § P < 0.001) Thermal sensitivity was assessed by the planter test. Low-threshold mechanical sensitivity was assessed by the von Frey test. Thermal and mechanical hypersensitivity were observed on the ipsilateral side after chronic constriction injury. day 15 (BDNF and 5HT2CR P < 0.01; N = 6). The relative expression of 5HT2AR mRNA on day 15 was lower than those in the other two groups (P < 0.01; N = 6). The mRNA expression of GABAAb1R and NR2A increased only on day 15 (P < 0.01; N = 6). 5HT1AR and 5HT3AR mRNA expression increased on day 7 and decreased to levels similar to the control group on day 15 (5HT3AR P < 0.001; N = 6, 5HT1AR P < 0.01; N = 6). The expression level of GABABb1R was not significantly different among the three groups (N = 6).
Discussions
The hippocampus is not directly involved in the pain pathway, but many reports indicate a relationship between the hippocampus and pain memory [21] or psychological symptoms such as loss of appetite [7] and anxiety [8, 9] . Neuropathic pain or stress has been reported to be related not only to the pain pathway but also to the limbic system via the frontohippocampal circuit [5] and pituitary adrenal axis [6] . There are only a few reports of miRNA 5HT3A NPY BDNF 5HT1A = serotonin 1A receptor; 5HT2A = serotonin 2A receptor; 5HT2C = serotonin 2C receptor; 5HT3A = serotonin 3A receptor; BDNF = brain-derived neural factor; GABAAa1 = gamma-aminobutyric acid A a1 receptor; GABAAb1 = gamma-aminobutyric acid A b1 receptor; GABABb2 = gamma-aminobutyric acid B b2 receptor; miRNA = microRNA; mRNA = messenger RNA ; NPY = neuropeptide Y; NR2A = N-methyl-D-aspartate glutamate 2A receptor.
changes in neuropathic pain models [14, 15] . Our TLDA data confirmed the tendency for statistically significant miRNA changes to be observed until day 7 after initiation of CCI and recovered by day 15, as shown in the cluster analyses. As in previous reports [14] , qRT-PCR performed to validate TLDA data indicated that the quality of TLDA may be reliable. The genetic changes observed in this study are listed in Table 2 . In particular, miR-132 is known to be related to dendrite growth control [10] and short-term synapse plasticity in the hippocampus [11] . miR-132 regulates BDNF [22] and NR2A expression through BDNF changes [23] , while miR-125b regulates NR2A [24] . Most mRNAs showed apparent changes on day 7 and recovered to the same levels as the control groups by day 15, just like the miRNA expression changes.
The relationship between the hippocampus and NR2A, GABAR, and serotonin R suggests that the hippocampus has an inhibitory role in neuropathic pain via the descending antinociceptive system (DAS). GABAR is contained in the inhibitory neurons and interneurons included in the DAS and is considered to be related to pain inhibition [25] . It has been reported that the sensitivity of neuropathic pain to a drug might be based upon the amount of BDNF expression in the hippocampus [26] , which also suggests that decreased BDNF expression increases neuropathic pain. NPY is an inhibitory neurotransmitter acting mainly on the hippocampus and frontal cortex [27] that has been reported to increase inhibitory interneurons in the hippocampus [28] . Moreover, NPY acts on GABAAR [29, 30] and is considered to accelerate the DAS. Regarding serotonin R, 5HT2AR has been reported to operate on the frontohippocampal circuit [5] , and increasing 5HT1AR and 5HT2AR in the hippocampus may evoke anxiety [8, 9] . Furthermore, 5HT2CR is a target of antidepressants and important in psychiatric behaviors or psychiatric-related molecular balances [31] . Unfortunately, the miRNAs that control the serotonin receptors in rats are not well known according to online databases. In the first week after CCI, the expression of miR-125b and -132 decreased, and mRNA expressions of BDNF and NPY decreased. These changes might increase neuropathic pain. In the second week after CCI, miR-125b expression increased, and mRNA expressions of NPY, BDNF, and NR2A increased. These changes may slightly alleviate allodynia.
Our study has some limitations. Our data are not sufficient to conclude a direct relationship between these miRNAs, their proposed mRNA targets, and the behavioral changes. The changes in mRNAs and miRNAs from day 1 to day 6 remain unclear, and additional experiments are needed. Further research is also needed to reveal gene changes in other neuropathic pain models or in other parts of the nervous system. As potential targets of therapy, inhibition of mRNA and miRNA changes might reduce behavior in a neuropathic pain model. Adding inhibitors or precursors may give clues to possible therapy.
Conclusions
In this report, we examined the gene changes in rats during the first 2 weeks after CCI operation. TLDA showed that miRNAs tended to change by day 7 and recover by day 15. Our data indicated that a peripheral nerve injury altered the hippocampal gene expressions, which may partly explain the causes of symptoms of neuropathic pain. shown as *P < 0.05, **P < 0.01, and § P < 0.001. 5HT1AR = serotonin 1A receptor; 5HT2AR = serotonin 2A receptor; 5HT2CR = serotonin 2C receptor; 5HT3AR = serotonin 3A receptor; BDNF = brain-derived neural factor; GABAAa1R = gamma-aminobutyric acid A a1 receptor; GABAAb1R = gamma-aminobutyric acid A b1 receptor; GABABb2R = gamma-aminobutyric acid B b2 receptor; NPY = neuropeptide Y; NR2A = N-methyl-D-aspartate glutamate 2A receptor.
